Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.
D002746:Chlorpromazine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005476:Fluphenazine / Q000627:therapeutic use*; D006801:Humans; D010259:Paranoid Disorders / Q000150:complications*; D010640:Phenothiazines / Q000627:therapeutic use; D011581:Psychological Tests; D012559:Schizophrenia / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome / Q000150:complications*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D010640:Phenothiazines; D014149:Tranquilizing Agents; D005476:Fluphenazine; D002746:Chlorpromazine